Your browser doesn't support javascript.
loading
End Points for Clinical Trials in Hyperoxaluria: Case Study of Patient-Focused Drug Development in a Rare Disease.
Lieske, John C; Malley, Meaghan A; West, Melissa; Hollander, Kim; Milliner, Dawn S.
Afiliação
  • Lieske JC; Division of Nephrology, Mayo Clinic, Rochester, Minnesota. Electronic address: Lieske.John@mayo.edu.
  • Malley MA; American Society of Nephrology, Washington, DC.
  • West M; American Society of Nephrology, Washington, DC.
  • Hollander K; Oxalosis and Hyperoxaluria Foundation, New Paltz, New York.
  • Milliner DS; Division of Nephrology, Mayo Clinic, Rochester, Minnesota.
Am J Kidney Dis ; 79(5): 754-756, 2022 05.
Article em En | MEDLINE | ID: mdl-34634431
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperoxalúria / Hiperoxalúria Primária Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperoxalúria / Hiperoxalúria Primária Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article